EVOKE PHARMA INC
CUSIP 30049G203
Evoke Pharma Inc has 11 institutional holders in Filings Flow’s 13F database, together reporting 3.79M shares worth $2M as of Q2 2024. The largest reported holders are Nantahala Capital Management, LLC, Aigh Capital Management LLC, and Bleichroeder LP.
Institutional Holders
11
Q2 2024
Reported Value
$2M
Ticker
unmapped
private placement or foreign
Quarters Tracked
9
Ownership Trend
Institutional holders
Total reported value
Holders
··Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Nantahala Capital Management, LLC$2.7B AUM | 0.02% | $714,150 | 1.35M | Q2 2024 |
| AIGH Capital Management LLC$733M AUM | 0.14% | $447,832 | 846.6K | Q2 2024 |
| Bleichroeder LP$579M AUM | 0.13% | $436,425 | 825.0K | Q2 2024 |
| Altium Capital Management LLC$42M AUM | 0.15% | $366,301 | 692.4K | Q2 2024 |
| GEODE CAPITAL MANAGEMENT, LLC$1.61T AUM | 0.00% | $26,286 | 49.7K | Q2 2024 |
| MILLENNIUM MANAGEMENT LLC$240.3B AUM | 0.00% | $6,630 | 10.9K | Q1 2024OLDER |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $6,301 | 11.9K | Q2 2024 |
| Tower Research Capital LLC (TRC)$3.8B AUM | 0.00% | $3,956 | 7.5K | Q2 2024 |
| BlackRock Finance, Inc.$4.42T AUM | 0.00% | $774 | 1.5K | Q2 2024 |
| UBS Group AG$666.3B AUM | 0.00% | $586 | 1.1K | Q2 2024 |
| NewEdge Advisors, LLC$27.7B AUM | 0.00% | $110 | 208 | Q2 2024 |
| Concord Wealth Partners$770M AUM | 0.00% | $43 | 31 | Q3 2023OLDER |
| CWM, LLC$38.1B AUM | — | $0 | 16 | Q4 2023OLDER |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM | — | $0 | 0 | Q2 2024 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.